Clinical Care


Guidelines for type 2 diabetes - designed to help newly diagnosed children and adolescents

The prevalence of childhood obesity has increased dramatically worldwide with potentially dire consequences to the health of children and to their future. Drs. Warren Lee of Singapore and Stuart Brink of the USA introduce the new American Academy of Pediatrics guidelines for newly diagnosed type 2 diabetes in children and adolescents, explaining how the evidence-based recommendations are essential for all physicians involved in the care of children.

W.A.S.H. away the world’s dietary salt

The world’s current dietary salt consumption, more than twice the daily amount recommended, is rubbing the wound of declining public health. Increasing evidence suggests that a high salt intake may directly increase the risk of heart disease, stroke, obesity through soft drink consumption, and many other preventable diseases, including cancers. Restricting dietary salt is even more critical for high-risk populations, such as diabetes.

Debate: How low can you go? The low-down on the low carbohydrate debate in type 1 diabetes nutrition

As a means of representing relevant issues to the diabetes community, Diabetes Voice will be providing a forum in which experts can examine controversial issues and provide an argument supporting their point of view. The low carbohydrate debate marks the first in a series of many more to come.

Anthropometric indicators of obesity for identifying cardiometabolic risks in a rural Bangladeshi population – Chandra Diabetes Study

Professor Akhtar Hussain’s aim of studying anthropometric indicators of obesity was to evaluate the predictive ability of body mass index, waist circumference, waist-to-hip ratio, waist-to-height ratio and body fat percentages for the presence of cardiometabolic risks—namely type 2 diabetes, hypertension, dyslipidemia and the metabolic syndrome.

SGLT2 inhibitors – a useful addition to therapy?

SGLT2 stands for ‘sodium-glucose linked transporter 2’. This is a protein within the kidney tubules that regulates the reabsorption of glucose in the kidney. There is also, predictably, an SGLT1, which is present in both the kidney and the gut. In the kidneys, under normal circumstances, virtually all the glucose that passes into the urine from the blood is reabsorbed by the action of SGLT2.

Preventing diabetes-related amputations in a developing country – steps in the right direction

In Pakistan, between 4% and 10% of people with diabetes develop a foot ulcer, and more than 10% of those ulcers lead to an amputation. The ‘diabetic foot’ is saddling Pakistan’s already resource-constrained economy with a tremendous and growing cost burden. Significant achievements have been made in preventing diabetes-related foot ulcers and improving foot care throughout the country, including the implementation of a highly effective ‘Step by Step’ programme. Under the auspices of that programme, training is provided for physicians, diabetes educators and foot care assistants.

Depression and diabetes - a significant challenge with diabetes and healthcare providers

A diagnosis of diabetes is always stressful. People are suddenly faced with having to manage a complex treatment regimen, including amended diet, regular monitoring and pharmacological therapies, often leading to a variety of new fears and responsibilities about their health. Problems with emotional adjustment to the condition can have negative effects on diabetes self-management – which in turn can impact on emotional wellbeing, in a classical vicious cycle.

Managing diabetes during fasting - a focus on buddhist lent

Ritual fasting is an essential part of many major faiths. Lent in Christianity, Ramadan in Islam, Yom Kippur in Judaism, or the Navratras in Hinduism – fasts vary in duration and in degree. Some ritual fasts pose challenges to the physical health and fitness of those following the ritual, which are significant in people with diabetes, who have metabolic disorders and use treatments that impair their capacity to fast for long periods of time.

IDF breaking new ground – building bridges around the world

With its latest round of funding complete, the International Diabetes Federation’s translational research programme, BRIDGES, has raised its game again, receiving 57 applications from 32 countries. This round of financial support ensured USD 65,000 per project and was dedicated to short-term projects lasting a maximum two years. Having undergone rigorous screening by recognized experts, nine of the projects were selected and will benefit from financial backing from IDF. Ronan L’Heveder describes the latest innovative projects to quality for BRIDGES funding.

Exploring ethnicity in people with type 2 diabetes in Australia

In 2011, the Royal Prince Alfred Hospital Diabetes Centre in Sydney, Australia, joined the voluntary network of International Diabetes Federation (IDF) Centres of Education. There are currently eight such centres providing excellent diabetes care and education services in Latin America, Asia (including the Indian sub-continent and China), Europe and now Australia. Central to the aims of the Centres of Education are efforts to increase regional capacity to respond to the diabetes epidemic.